Xella Adds Oura Data to Its $499-a-Year Women’s Health Service

Connecting an Oura ring to women’s health care comes with a separate bill: Xella Health costs $499 a year. TechRadar’s October 1 coverage details access to the integration, which lets eligible U.S. members share wearable readings for analysis alongside lab testing and clinical care. Residents of New York and New Jersey are excluded.

Xella announced the partnership on September 23, 2026. Its pitch addresses a gap between noticing a change and understanding it: a wearable can show shifting sleep, temperature or recovery patterns, while Xella aims to connect those observations with biological testing and physician-guided treatment.

The company frames fatigue, irregular menstrual cycles, fertility challenges, weight changes and perimenopause as reasons women may seek more answers.

From a ring trend to a care plan

The process starts with a member’s choice to share data. Supported readings include sleep, resting heart rate, temperature trends, recovery, activity and menstrual-cycle insights.

The company calls its testing “multi-omic” diagnostics: it considers several layers of biological information rather than relying on a ring reading alone.

The next step is clinical care, not simply another score in a wearable app. Xella says physician-guided plans provide personalized interventions and treatments. TechRadar describes the AI as creating a care plan with a doctor, keeping a clinician involved in the move from analysis to treatment.

Wearables have transformed our ability to detect physiologic change.

Kelly Lacob, Xella Health CEO and co-founder

The connection continues during treatment

The integration is designed to remain useful after an initial assessment. Xella clinicians can view shared Oura trends beside diagnostic results and member check-ins as care continues. That gives them a record over time, rather than a single snapshot, to consider alongside a member’s conditions, goals and care plan.

Xella names fertility optimization, perimenopause, hormonal health, cardiometabolic health and women’s longevity as the partnership’s focus areas.

Xella also says its broader platform can identify more than 130 conditions specific to female biology.

Access has a price—and a medical boundary

For prospective users, the practical requirements are narrower than simply owning a ring:

• A Xella membership is required; its $499 annual fee is separate from an Oura subscription.
• Eligible users must be in the United States, excluding New York and New Jersey.
• Members choose whether to share their Oura insights with Xella.

Xella’s announcement explicitly states that Oura is not a medical device. The wearable supplies trends; Xella’s diagnostics and physician-guided care supply the clinical layer described in the partnership.

The unresolved question is whether that extra stream of everyday readings helps clinicians make better care decisions. Xella’s stated ambition is to explain changes and personalize treatment over time. For a member, the meaningful test would be better answers or care—not merely having more measurements collected in one place.